• Aucun résultat trouvé

Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative

N/A
N/A
Protected

Academic year: 2021

Partager "Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: hal-01880046

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01880046

Submitted on 7 Dec 2018

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane

Oxygenation as a Life-saving Alternative

Raphaël P Martins, Erwan Flecher, Solène Le Pennec-Prigent, Vincent Galand

To cite this version:

Raphaël P Martins, Erwan Flecher, Solène Le Pennec-Prigent, Vincent Galand. Antiarrhythmic Drugs Are not the Only Option in Electrical Storm: Extracorporeal Membrane Oxygenation as a Life-saving Alternative. Revista Española de Cardiología (English version), Elsevier España, 2019, 72 (2), pp.184.

�10.1016/j.rec.2018.08.007�. �hal-01880046�

(2)

Accepted manuscritpt

Letter to the Editor

AntiarrhythmicDrugsArenottheOnlyOptioninElectricalStorm:

ExtracorporealMembrane OxygenationasaLife-savingAlternative

Losfa´rmacosantiarrı´tmicosnosonlau´nicaopcio´nenla tormentaele´ctrica:Eloxigenadorextracorpo´reode membranaesunaalternativa

TotheEditor,

We read with great interest the scientific letter by Garcı´a Carren˜ oetal.1publishedinRevistaEspan˜oladeCardiologı´a.Inthat study, the authors retrospectivelyanalyzed their patients who underwent venoarterial extracorporeal membrane oxygenation (VA-ECMO)implantationinthecontextofelectricalstorm.Seven patients were included, all but 1 withischemic heart disease.

Following VA-ECMO implantation, 4 patients had a ventricular tachycardiaablationprocedureand2died.Themediandurationof supportwas9days.TheauthorsconcludethatVA-ECMOsupport should be systematically evaluated in patients with refractory ventricular tachycardia and cardiogenic shock since it ensures hemodynamicsupportinthesecritically-illpatients,allowingVT ablationtobesafelyperformed.

We completely agree with these statements. Indeed, we recently published a similar study including 26 patients with refractoryelectricalstormandcardiogenicshockimplantedwitha VA-ECMO.2 Interestingly,stable sinusrhythm wasimmediately obtainedafterVA-ECMOimplantationintwo-thirdsofthepatients and occurred afteramedian timeof 3hoursfortheremaining ones.Fiftypercentofthepatientseventuallydied,noneduetothe VA-ECMO,butmostlyduetomultipleorganfailure.Theaverage durationofVA-ECMOsupportwas6.73.6days.Ofnote,survival was significantly better in patients with repetitive ventricular tachycardia/fibrillationalternatingwithperiodsofsinusrhythmat the time ofVA-ECMO implantationthan in those withrefractory ventricularfibrillation.Tothebestofourknowledge,our

study is

the

largestdatabaseofVA-ECMOimplantationinpatientswithelectrical storm published thus far.

Ourresultshadanimpactinthefieldofintensivecaremedicine, buthadlesseffectincardiology,sincecardiologists,andespecially electrophysiologists,aremorelikelytoattemptmultipleantiar- rhythmictherapies,performelectricalcardioversions,andconsid- er ablation, rather than call interventional cardiologists or surgeonstoimplantaVA-ECMOforanarrhythmicproblem.This reluctance probably explains why VA-ECMO is an underused deviceinpatientswithelectricalstorm.Patientsendupdyingfrom

multipleorganfailure,asaconsequenceofsuboptimallymanaged electricalstorm,whilethecomplicationsofVA-ECMOarerare,as demonstrated by Garcı´a Carren˜ o et al.1 and by our study.2 Physiciansshouldkeepinmindthatinpatientswithintractable electrical storm and cardiogenic shock refractory to usual management,VA-ECMOprovidesefficienthemodynamicsupport andhelpstorapidlyrestoresinusrhythm,probablyduetorapid improvement of myocardial perfusion and a decrease in left ventricularend-diastolicpressure.

TheevidencesupportingtheuseofVA-ECMOinelectricalstorm isscarceandisespeciallyfocusedontheuseofVA-ECMOduring ventriculararrhythmiaablationandnotasanadjunctivetherapy perse.3,4Thus,wecongratulateRevistaEspan˜oladeCardiologı´afor showing interest in this topic and the authors for once again demonstrating that electricalstorm can,of course, bemanaged pharmacologicallyandbyablation,butalsobyVA-ECMOimplanta- tion,sinceitmightprovidesuccessfuloutcomes,preventingsecon- daryorgandamageandmaintainingsufficientcardiacunloading. Q2 Raphae¨lP.Martins

Q1 ,a,b,c,*ErwanFlecher,a,b,c

Sole`neLePennec-Prigent,a,b,candVincentGalanda,b,c

aUniversite´ deRennes,Rennes,France

bServicedeCardiologie,CentreHospitalierUniversitairedeRennes, Rennes,France

cInstitutNationaldelaSante´ etdelaRechercheMe´dicale(INSERM), U1099,Rennes,France

* Correspondingauthor:

E-mailaddress:raphael.martins@chu-rennes.fr(R.P.Martins).

REFERENCES

1. Garcı´aCarren˜oJ,Sousa-CasasnovasI,VicentAlaminosML,AtienzaFerna´ndezF, Martı´nezSelle´sM,Ferna´ndezAvile´sF.ExtracorporealMembraneOxygenationin PatientsWithElectricalStorm:ASingle-centerExperience.RevEspCardiol.2018.

http://dx.doi.org/10.1016/j.rec.2018.07.001.

2. LePennec-PrigentS,FlecherE,AuffretV,etal.EffectivenessofExtracorporealLife SupportforPatientsWithCardiogenicShockDueToIntractableArrhythmicStorm.

CritCareMed.2017;45:e281–e289.

3. BarattoF,PappalardoF,OlorizT,etal.ExtracorporealMembraneOxygenationfor HemodynamicSupportofVentricularTachycardiaAblation.CircArrhythmElectro- physiol.2016.9:pii:e004492.

4. Tsai FC,Wang YC,HuangYK, etal. Extracorporeallife supportto terminate refractoryventriculartachycardia.CritCareMed.2007;35:1673–1676.

12 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45

46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 80 81 82 83 84 85 86 87 88 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 80 81 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 80 81 82 83 84 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 7778 79 80 81 82 83 84 85 86 87 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 7778 79 80 81 82 83 84 85 86 87 88 89 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 7980 81 82 83 84 85 86 87 88 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 80 81 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 7879 80 81 82 83 84 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 80 81 82 83 84 85 8687 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74

75 76 77 78 79 80 81 82 83 84 85 8687 88 89

Références

Documents relatifs

We present a novel method for inferring tissue labels in atlas- based image segmentation using Gaussian process regression.. Atlas-based segmentation results in probabilistic label

The main challenges and research opportunities on how the analysed trust and reputation based systems, as an influence measure to foster decision making processes and

Boxplot of RT-qPCR data of lsr mRNA expression in different brain regions of 3-month-old female C57Bl/6JRj mice (n = 3) with respect to 3-month-old male C57Bl/6JRj mice (n = 3)..

The aim of this study was to conduct an ethno-botanical survey among traditional healers from Sahel region of Burkina Faso to identify possible anti-malarial and anti-mosquito plants

In this context, we present here ArthropodaCyc, a dedicated BioCyc collection of databases using the Cyc annotation database system (CycADS), allowing researchers to perform

The Future subject pronoun is followed by a floating Hi tone raising the first tone of the following Verbal Noun from Lo to Hi?. at tomorrow Musa FUT cut- VN meat

Review of ”�arawa lexicon: a wordlist of eight South Bauchi (West Chadic) languages: Boghom, Buli, Dott, Geji, Sayanci and Zul” by Ronald Cosper, Munich: LINCOM EUROPA, 1999...